Zim Laboratories Ltd. (ZIMLAB) — BSE Stock Analysis
Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Share price: ₹123.00.
Company Overview
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
Valuation Snapshot
- Market cap: —
- P/E: —
- P/B: —
- ROE: —
Blanket Finance is not a SEBI-registered investment adviser or research analyst. This content is for educational and informational purposes only.